Foghorn Therapeutics Inc (FHTX) — Strategic Asset Allocation Index
Foghorn Therapeutics Inc (FHTX) has a Strategic Asset Allocation Index of 44104.5% as of December 2022. Strategic assets (PP&E of $49.40 Million plus long-term investments of $-) total $49.40 Million, measured against net assets of $112.00K. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check financial resilience of Foghorn Therapeutics Inc to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Foghorn Therapeutics Inc Strategic Asset Allocation Index (2020–2022)
This chart shows how Foghorn Therapeutics Inc's Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of December 2022, the index stands at 44104.5%, representing strategic assets of $49.40 Million against net assets of $112.00K USD. See FHTX free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Foghorn Therapeutics Inc (2020–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Foghorn Therapeutics Inc from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see how much is Foghorn Therapeutics Inc worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 44104.5% | $49.40 Million | $49.40 Million | $- | $112.00K | ▲ +44046.6 pp |
| 2021 | 57.9% | $56.08 Million | $56.08 Million | $- | $96.87 Million | ▲ +15.3 pp |
| 2020 | 42.6% | $62.33 Million | $62.33 Million | $- | $146.19 Million | — |